AP
SGEN

Antipodes Partners’s Seagen Inc. Common Stock SGEN Stock Holding History

Antipodes Partners’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-636,770
Closed -$135M – 81
2023
Q3 		$135M Buy
636,770
+79,541
+14% +$15.9M 4.34% 7
2023
Q2 		$107M Sell
557,229
-34,113
-6% -$6.78M 3.7% 11
2023
Q1 		$120M Buy
591,342
+22,895
+4% +$3.67M 4.15% 7
2022
Q4 		$73.1M Buy
568,447
+153,439
+37% +$19.8M 2.62% 18
2022
Q3 		$56.8M Buy
415,008
+116,585
+39% +$19M 2.28% 20
2022
Q2 		$52.8M Sell
298,423
-124,029
-29% -$17.9M 2.2% 22
2022
Q1 		$60.9M Buy
422,452
+40,102
+10% +$5.43M 2.16% 19
2021
Q4 		$59.1M Buy
382,350
+71,162
+23% +$11.9M 2.12% 19
2021
Q3 		$52.8M Buy
+311,188
New +$48.4M 1.81% 23

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $203M AUM 38.37% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Antipodes Partners's SGEN Position: Q4 2023 in Review

Antipodes Partners sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 636,770 shares — an estimated $135M sold.

Antipodes Partners first reported a position in SGEN in Q3 2021 and held it in 9 quarters. The position peaked at $135M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Antipodes Partners reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Antipodes Partners sold 636,770 Seagen Inc. Common Stock shares in Q4 2023, an estimated $135M.
  • Antipodes Partners first reported a position in Seagen Inc. Common Stock in Q3 2021 and held it in 9 quarters.
  • Antipodes Partners's Seagen Inc. Common Stock position peaked at $135M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Antipodes Partners's 13F filing for Q4 2023, filed 24 Jan 2024.